Search

everythinglearnresearchcommunity

for

Search:↓

Skin color may change how alopecia areata looks under a dermoscope.

Alopecia areata causes varying hair loss and nail changes, and treatments include topical, systemic, and injectable therapies.

Congenital triangular alopecia and vitiligo can occur together, but treatment for one may not affect the other.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

Scalp cooling can help prevent hair loss from chemotherapy, but treatment should be tailored to the individual and more research is needed.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Androgenetic alopecia significantly affects quality of life, especially for women, who are more willing to pay for treatment.

Patients with androgenetic alopecia have thinner subcutaneous fat layers in their frontal scalp compared to healthy individuals.

Both PRP and MZT treatments can significantly improve hair growth in patients with androgenetic alopecia.

Hair loss significantly lowers life quality, especially in young men, with most patients unhappy with treatment effectiveness.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Trichoscopy effectively diagnoses early female hair loss, but may need scalp biopsy for confirmation.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Dutasteride mesotherapy showed mixed results and is not recommended as a primary treatment for hair loss.

Hair loss in Saudi Arabia causes a low psychosocial impact, with less effect on those without a family history of hair loss.

Androgenetic alopecia is more common in Saudi men than women.

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

A witch-hazel-based 5% minoxidil solution is effective and safe for women with hair loss who didn't respond to regular minoxidil, especially if they're sensitive to propylene glycol.

Androgenetic alopecia negatively affects quality of life, especially in younger, less educated, single, and rural individuals.

Detailed history and physical examination are crucial for diagnosing hair loss.

Microneedling is promising for treating various skin issues but needs more research to confirm its effectiveness and safety.

Minoxidil and finasteride effectively treat hair loss.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Scalp cooling effectively reduces hair loss from chemotherapy.

Platelet-Rich Plasma (PRP) therapy can promote hair growth and improve facial aesthetics, including reducing acne scars and facial burns, and it works best with three initial monthly injections.